课题基金 / 基金详情

Multi-Omics Characterization of Plasmodium Vivax Hypnozoites

Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
间日疟原虫休眠子的多组学表征
批准号:
10565802
负责人:
David Serre
金额:
$72.51万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-12-22 至 2027-11-30

项目摘要

项目成果

David Serre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Plasmodium vivax parasites threaten half of the world’s population and are surprisingly resilient to on-going malaria elimination efforts, partially due to their ability to remain dormant in the liver as hypnozoites for weeks or months. Here, we propose to conduct state-of-the-art transcriptomic, epigenomic and lipidomic analyses using materials collected from non-human primates infected with P. vivax, and in vitro infections of human hepatocytes with patient-derived P. vivax sporozoites. Our analyses will provide a comprehensive perspective on the molecular and cellular mechanisms underlying the onset, maintenance and exit of P. vivax dormancy, and well as on the response of the host, from the infected hepatocytes to the organ- and organism-wide responses. Our findings will not only provide a better understanding of the fundamental processes underlying the fate and development of liver-stage P. vivax parasites but will also provide a solid foundation to develop better malaria vaccines and therapies against this important but understudied human pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host and parasite factors influencing P. vivax RBC invasion and asexual development
  • 批准号:
    10641026
  • 项目类别:
  • 资助金额:
    $70.63万
  • 财政年份:
    2022
  • 负责人:
    David Serre
  • 依托单位:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
  • 批准号:
    10372166
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2021
  • 负责人:
    David Serre
  • 依托单位:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
  • 批准号:
    10189044
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2021
  • 负责人:
    David Serre
  • 依托单位:
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
  • 批准号:
    10219069
  • 项目类别:
  • 资助金额:
    $63.96万
  • 财政年份:
    2020
  • 负责人:
    David Serre
  • 依托单位:
海外基金